Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers

Abstract

Background Emerging evidence suggests that LMNB1 is involved in the development of multiple cancer types. However, there is no study reporting the potential role of LMNB1 in a systematic pan-cancer manner. Methods The gene expression level and potential oncogenic roles of LMNB1 in The Cancer Genome Atlas (TCGA) database were analyzed with Tumor Immune Estimation Resource version 2 (TIMER2.0), Gene Expression Profiling Interactive Analysis version 2 (GEPIA2), UALCAN and Sangerbox tools. Pathway enrichment analysis was carried out to explore the possible mechanism of LMNB1 on tumorigenesis and tumor progression. The therapeutic effects of LMNB1 knockdown combined with PARP inhibition on human cancers were further investigated in vitro. Results LMNB1 upregulation is generally observed in the tumor tissues of most TCGA cancer types, and is verified in kidney renal clear cell carcinoma using clinical specimens of our institute. High level of LMNB1 expression usually predicts poor overall survival and disease free survival for patients with tumors. Mechanically, LMNB1 level is positively correlated with CD4+ Th2 cell infiltration and DNA homologous recombination repair gene expression. In vitro experiments reveal that targeting LMNB1 has a synergistic effect on prostate cancer with PARP inhibitor treatment. Conclusions LMNB1 is a biomarker of CD4+ Th2 cell infiltration and DNA homologous recombination repair in human cancers. Blockage of LMNB1 combined with PARP inhibitor treatment could be a promising therapeutic strategy for patients with cancers.

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer

“…Normally, the Th1/Th2 ratio is in equilibrium. It was shown that cytokines released by Th2 cells and Th2 are elevated in various human cancers ( 36 ) and patients with a Th2-dominant response have a worse prognosis than patients with Th1/Th2 balance ( 37 , 38 ). We also found that in LIHC, THCA, KIRP, and KIRC, the KIFscore was positively correlated with Treg cells.…”

Novel polymorphisms in CYP4A22 associated with susceptibility to coronary heart disease

“…Interaction analysis with of CYP4A22 polymorphisms with covariate (age, gender, smoking and drinking) was performed using SNPStats. Using the SangerBox database to visualize the significant results of the stratified analysis and the forest map was drawn ( https://www.snpstats.net/start.htm?q=snpstats/start.htm ) [ 17 ]. In addition, since multiple hypothesis tests may increase the false positive probability, we used FPRP (false-positive report probability) to detect whether a positive result is noteworthy (FPRP threshold is 0.2 and prior probability level is 0.25).…”

Tumor biomarkers for diagnosis, prognosis and targeted therapy

“…A high level of lamin B1 expression predicts poor OS and DFS for cancer patients. 875 Lamin B1 is overexpressed and facilitates cell proliferation and metastasis in HCC, and increased lamin B1 expression indicates a dismal prognosis and immunotherapy response in HCC. 876 Besides, lamin B1 has been proposed as a prognostic senescence biomarker in ccRCC 877 and lung adenocarcinoma.…”